Jewish 100, 2014: Ephrat Levy-Lahad – Innovation and Activism
×
Error: Contact form not found.
by Algemeiner Staff
Ephrat Levy-Lahad
Medical researcher
All women of Ashkenazi origin should be screened for two breast-cancer predisposition genes from the age of 30, said Prof. Ephrat Levy-Lahad, the head of a leading research team at Shaare Zedek Medical Center. Levy-Lahad’s 2014 announcement, which received international attention, was a departure from the previous guideline of testing for the two BRCA genes only if a close blood relative contracted breast or ovarian cancer. The finding will likely change screening practices in Israel and in Jewish communities worldwide, ultimately saving lives.
Colombia to Withdraw Support for South Africa’s ICJ Genocide Case Against Israel as Ties with Jerusalem Are Restored
Israel Hosts Lawmakers from Seven US States for Grand Tour of Holy Sites and Jewish Democracy
Top House Democrat Cites Vandalism, Arson, and Assault by Anti-Israel Activists as He Votes to Cut Israel Aid
Anne Frank, Primo Levi Murals in Italy Vandalized With Antisemitic Graffiti Yet Again
British Court Orders Anti-Israel Group to Pay More Than $110,000 After Failed Bid to Prosecute Israeli Reservist
Marcus Foundation Donates Whopping $27 Million to Hillel International to Support Campus Jewish Life
The GOP Base Still Stands With Israel; The Next Generation Is the Real Test
Gal Gadot Shares Trailer for New Movie ‘The Runner,’ Disrupted by Anti-Israel Activists While Filming in London
Israeli Team Wins 5 Medals, Including Gold, at International Physics Olympiad in Colombia
Devarim and the Man Who Refuses to Be Broken










